Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Classement en actions #18093
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Prix de l'action
$4.47
Dernière synchronisation: 2025-08-20
Capitalisation boursière
$213.06M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange CARGO Therapeutics, Inc. Common Stock (CRGX)

Catégorie

Historique du prix de l'action pour CARGO Therapeutics, Inc. Common Stock (CRGX)
Prix de clôture le plus élevé : $4.48 le 2025-08-01

Prix de clôture le plus bas : $14.85 le 2023-11-01
Historique du prix de l'action de CARGO Therapeutics, Inc. Common Stock de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -71.01%
2024 -16.24%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.68 -9.23%
AU
$757.71 6.76%
CH